Season 2022 Episode 30
ProMIS Neurosciences Inc. (NASDAQ: PMN | TSX: PMN) Chairman and CEO Eugene Williams talks to Global One Media to share the science behind targeting misfolded proteins to develop treatments for Alzheimer's disease, amyotrophic lateral sclerosis, multiple system atrophy, and other neurologic disorders. Williams also shares their exciting collaborations and partnerships to further advance the treatments in the life science sector.
Published on 3 years, 4 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate